HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 778.37 billion as of June 27, 2025. Its market cap has increased by 17.82% in one year.

Market Cap

778.37B

Enterprise Value

807.48B

Revenue

57.22B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,775.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 778.37B, an increase of 635.66%. That is a compound annual growth rate of 13.97%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	400.94B	-57.10%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	776.71B	0.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.10T
Celltrion	35.49T
ALTEOGEN	20.84T
Yuhan	7,589.05B
SK Biopharmaceuticals	7,236.14B
HLB Co., Ltd.	6,512.41B
PharmaResearch	4,992.23B
Peptron	4,741.01B

Market Cap Rankings